China Pharma Holdings, Inc.

CPHIAMEXUSD
1.18 USD
0.04 (3.51%)AT CLOSE (11:59 AM EDT)
1.16
0.02 (1.44%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
1.16
0.02 (1.44%)
🔴Market: CLOSED

China Pharma Holdings, Inc. (CPHI) trades at $1.18 per share. Our models show a "Neutral" technical signal alongside a "Strong Sell" fundamental rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, CPHI trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Aug 4, 2026.

Open?$1.13
High?$1.19
Low?$1.12
Prev. Close?$1.14
Volume?329.9K
Avg. Volume?8.6M
VWAP?$1.15
Rel. Volume?0.04x
Bid / Ask
Bid?$1.14 × 700
Ask?$1.18 × 400
Spread?$0.04
Midpoint?$1.16
Valuation & Ratios
Market Cap?46.2M
Shares Out?40.5M
Float?2.0M
Float %?4.8%
P/E Ratio?N/A
P/B Ratio?1.25
EPS?-$0.09
Dividend?0.00%
Ex-Dividend?N/A
RelatedUTZ
News
Profile
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
Employees
221
Market Cap
46.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2002-04-14
Address
2ND FLOOR, NO. 17, JINPAN ROAD
HAINAN PROVINCE, F4 570216
Phone: 8689866811730
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
23
Momentum?
17
Short Sent.?
34
Piotroski F-Score?2/9Weak
Altman Z-Score?1.60Distress
Confidence?68%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?21.10%Squeeze Risk
Short Interest?413.8K
Days to Cover?1.0
Free Float2.0M
Avg Daily Volume11.8M
Settlement Date2026-07-15
Financial Health
Current Ratio?0.28Weak
Quick Ratio?0.07Weak
Cash Ratio?0.02Low
Debt/Equity?0.09Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
60/100
P/E?
N/A
P/B?
Peers
100
S&P
92
1.25CHEAP
P/S?
Peers
50
S&P
6
11.57HIGH
P/FCF?
Peers
50
S&P
3
308.4PRICEY
EV/EBITDA?
Peers
100
S&P
97
-34.3CHEAP
EV/Sales?
Peers
50
S&P
7
12.38HIGH
Returns & Efficiency
ROE?
S&P
9
-9.6%WEAK
ROA?
S&P
3
-7.9%WEAK
Cash Flow & Enterprise
FCF?$149.8K
Enterprise Value?$49.4M
Fundamentals ratios updated end of day